What Is Breakthrough Therapy Designation?
Breakthrough therapy designation is an FDA status for drugs that show preliminary clinical evidence suggesting the therapy may offer substantial improvement over existing options for one or more serious or life-threatening conditions. In biotech, the designation matters because it can accelerate development and increase the level of interaction between the company and the FDA.